儿童期癌症幸存者承受着由治疗引起的大量慢性疾病负担（“62%有严重慢性疾病”）。
原始表述
وعبء أمراض مزمنة شديدة لدى 62% من الناجين من سرطان الطفولة
非原话——为转述. 译文由本项目提供；以阿拉伯语原文为准。
译文
儿童期癌症幸存者承受着由治疗引起的大量慢性疾病负担（“62%有严重慢性疾病”）。
出处
- 来源状态
- 档案网站编辑
- 归属
- Archive editors (rule page summary/narrative)
- 出处
- https://eltayebat.com/rule/chemo-radiation/
- 归属的不确定性
- Written by archive operators; not attributed to Elawady.
- 所声称的机制
Late toxicity of radiotherapy and chemotherapy
- 所声称的健康影响
Chronic conditions, late mortality
- 涉及人群
Adult survivors of childhood cancer
- Elawady 设定的地域限制
none found
科学评估
基本正确 – 核心内容正确，但有局限或细微不准确之处。
证据确定性: 高 – 进一步研究极不可能改变该评估。
1. 说法是什么？
62% of childhood-cancer survivors have severe chronic conditions; 41% of late deaths are health-related.
2. 哪些内容可证实是正确的？
62.3% had at least one chronic condition and 27.5% a severe or life-threatening one (A-CHM-12); survivors have 5-6-fold relative hazards of cardiac disease (A-CHM-03); 41% of late deaths were health-related (A-CHM-11).
3. 哪些内容是错误或夸大的？
The summary's 'severe chronic conditions in 62%' is wrong: 62% had any condition (including mild), 27.5% a severe one. The cohorts were treated 1970-1999; late mortality fell from 12.4% to 6.0% as treatment intensity was reduced (A-CHM-11). These are survivors of cancers that are often fatal without treatment; childhood ALL 5-year survival reached 90.4% (I-CHM-05).
4. 哪些内容仍不明确？
Burden under current protocols.
5. 哪些研究支持该说法？
6. 哪些研究与该说法相矛盾？
7. 对德国和欧洲而言情况如何？
Long-term follow-up clinics for survivors exist in Europe.
8. 关于埃及的已知情况是什么？
No data reviewed.
9. 合理的实际结论是什么？
幸存者需要终身接受基于风险的随访；这一负担是生存的代价，而且正在下降。
评估详情
- 证据确定性的依据
Large CCSS cohorts are consistent; the archive summary misstates the 62% figure as 'severe'.
- 来源质量
Correct featured card; summary error.
- 地区可推广性
Moderate.
- 说法的地域范围
- 普遍性（生物学/医学）
- 最近审核
- 2026年10月26日 初步
科学证据详解
有充分科学证据支持 – 该说法与一致的高质量证据相符。
研究问题: Do childhood-cancer survivors carry a large burden of treatment-related chronic disease, and is '62% severe' correct?
研究问题详解 (PECO)
- 人群
- Long-term survivors of childhood cancer
- 干预或暴露
- Childhood cancer treatment
- 对照
- Siblings or community controls; earlier treatment eras
- 地域范围
- universal biology; data mainly North American
- 结局指标
- Any chronic condition
- Severe (grade 3-5) conditions
- Trends over treatment eras
研究结果按作者报告呈现。我们的评估见下文。
哪些证据支持该说法？
Most adult survivors of childhood cancer live with at least one chronic health problem
CCSS: most survivors had at least one chronic condition.
- 实际结果
- 62.3% any; 27.5% grade 3-4; RR severe 8.2 vs siblings
- 方法学质量
- high (large cohort)
- 相关性
- direct
- 局限
- Self-report
Lifetime health problems after childhood cancer
Clinically assessed cohort: survivors had about twice the burden of serious conditions of community controls by age 50.
- 实际结果
- 4.7 vs 2.3 grade 3-5 conditions; 96% grade 3-5 cumulative incidence by age 50
- 方法学质量
- high (clinical assessment)
- 相关性
- direct
- 局限
- Single centre; imputation
哪些证据不支持该说法？
Are childhood cancer survivors getting healthier?
The burden of severe conditions declined across treatment eras.
- 实际结果
- 20-y grade 3-5 incidence 33.2% -> 27.5% (siblings 4.6%)
- 方法学质量
- high (cohort of 23,601)
- 相关性
- direct (limits 'fixed' burden)
- 局限
- Self-report; eras to 1999
总体证据说明了什么？
基于上述研究的编辑评估——其本身并非研究结果。
哪种观点有更好的证据支持？
A large burden exists; the archive mislabels 62% (any condition) as severe (27.5%), and the burden is declining with modified treatment.
为什么有些研究权重更大
Large cohorts with comparison groups.
因果关系是否已确立？ 是，已确立 Dose-response with radiation and anthracyclines; comparison with siblings; mediation by treatment changes.
仍存在的不确定性
Burden after current protocols.
合理的结论
Mostly true with a numerical misstatement.
为什么研究结果看起来互相矛盾？
Bhakta (clinical assessment, very high burden) vs Gibson (declining self-reported severe conditions): different measurement and eras; both agree burden is far above controls.
这是否取决于国家？
- 一般生物学效应
- Universal biology; Egyptian survivor late-effect data not found; Egyptian survival data (I-CHM-125) show most children now survive, so survivorship care is relevant there too.
- 饮食习惯
- Not relevant.
- 食品原产地
- Not relevant.
- 污染物
- Not relevant.
- 本国生产条件
- Not relevant.
- 法律规则
- Not relevant.
- 实际监测数据
- No monitoring data relevant.
足以改变结论的地区差异没有可靠数据支持。
统计复核
- Check '62% severe' – 62.3% any vs 27.5% severe: archive overstates severe share 2.3-fold 已重新计算
- Absolute decline – 5.7 points (17% relative) 已重新计算
总体证据的确定性（GRADE，简化版）
- 主要结局
- Severe chronic conditions in survivors
- 起始等级
- 低（观察性研究）
- 升级理由
- large effect (RR 8.2)
- 结果
- 高
由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。
检索策略
本次审查的文献检索记录（检索式采用原数据库语法）。
| 数据库 | 日期 | 检索式 | 检索目标 | 命中数 | 纳入数 |
|---|---|---|---|---|---|
| Europe PMC | 2026年10月26日 | TITLE:"Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer" | 反对性证据 | 1 | |
| Europe PMC | 2026年10月26日 | TITLE:"cumulative burden of surviving childhood cancer" | 支持性证据 | 2 | |
| Europe PMC | 2026年10月26日 | (TITLE:"Childrens Cancer Hospital Egypt" OR TITLE:"57357") AND (survival) | 双向 | 6 |
待解决的问题
Late effects in Egyptian survivors.
核查深度如何？
6 项相关研究：2 项核查了全文（其中 2 项进行了结构化偏倚风险评估），4 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。
最近一次科学审核: 2026年10月26日
通俗解释
许多在儿童期战胜癌症的成年人至少有一种长期健康问题；约四分之一的人有严重的健康问题。这些问题部分来自1970年代和1980年代的治疗方法。此后，医生降低了放疗和药物剂量，远期死亡人数减少了一半。如今，十个白血病患儿中有九个能够存活。
与该说法相关的研究
支持该说法的研究 (3)
-
Most adult survivors of childhood cancer live with at least one chronic health problem
Oeffinger KC et al.. N Engl J Med 2006 · PMID 17035650 · DOI 10.1056/NEJMsa060185队列研究被 Tayebat 档案网站引用已核查摘要★ 关键研究62% had at least one chronic condition and 27.5% a severe one.
62.3% any / 27.5% severe
该研究是否支持这一具体说法？ 是 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Measure chronic conditions after childhood cancer.
- 研究是如何开展的？
Cohort with siblings.
- 研究了多少人、动物或样本？
10,397 survivors.
- 实际发现了什么？
62.3% any; 27.5% severe.
- 观察到的效应有多大？
RR 8.2 for severe vs siblings.
- 研究结果对日常生活意味着什么？
Survivors need life-long follow-up.
- 该研究有哪些局限？
Self-report, old treatments.
- 它对 Elawady 的具体说法说明了什么？
Supports burden; archive summary misstates 'severe'.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
That these children would have been better without treatment.
-
Adult survivors of childhood cancer have more heart disease than their siblings
Mulrooney DA et al.. BMJ 2009 · PMID 19996459 · DOI 10.1136/bmj.b4606队列研究被 Tayebat 档案网站引用全文，含结构化偏倚风险评估★ 关键研究Survivors reported heart failure about 6 times as often as siblings (1.7% vs 0.2%); by 30 years after diagnosis about 4% had heart failure. Risk rose with anthracycline dose and heart radiation.
Survivor burden
该研究是否支持这一具体说法？ 是 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Quantify late heart disease in survivors.
- 研究是如何开展的？
Retrospective cohort with questionnaires.
- 研究了多少人、动物或样本？
14,358 survivors, 3,899 siblings.
- 实际发现了什么？
HR 5.9 CHF, 5.0 MI, 6.3 pericardial, 4.8 valvular versus siblings; 30-year cumulative incidence of CHF 4.1%.
- 观察到的效应有多大？
Relative hazards 5-6; absolute: CHF in 1.7% of survivors vs 0.2% of siblings.
- 研究结果对日常生活意味着什么？
Lifelong heart follow-up for survivors.
- 该研究有哪些局限？
Self-reported, unvalidated diagnoses; possible surveillance bias; few cardiovascular risk factors measured; treatments from 1970-1986.
- 它对 Elawady 的具体说法说明了什么？
Supports existence of late harm.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
Absolute risk per patient; that treatment should have been avoided.
-
Lifetime health problems after childhood cancer
Bhakta N et al.. Lancet 2017 · PMID 28890157 · DOI 10.1016/S0140-6736(17)31610-0队列研究独立交叉核查已核查摘要By age 50, survivors had on average 4.7 serious health conditions vs 2.3 in people without childhood cancer.
Clinically assessed survivors had about twice the burden of serious conditions of controls.
该研究是否支持这一具体说法？ 是 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Count all health problems in survivors
- 研究是如何开展的？
Clinical assessment cohort
- 研究了多少人、动物或样本？
3010 assessed survivors
- 实际发现了什么？
High burden
- 观察到的效应有多大？
4.7 vs 2.3 serious conditions by age 50
- 研究结果对日常生活意味着什么？
Survivors need lifelong check-ups
- 该研究有哪些局限？
Single centre; old treatments
- 它对 Elawady 的具体说法说明了什么？
Supports the burden claim
- 研究结果是否适用于德国和欧洲？
Moderate
- 从该研究中明确不能得出什么结论？
Cannot weigh this against the lives saved
该组中没有被标记为关键研究的研究。
与该说法相矛盾或限制该说法的研究 (1)
-
About 9 in 10 children with leukaemia now survive
Hunger SP et al.. J Clin Oncol 2012 · PMID 22412151 · DOI 10.1200/JCO.2011.37.8018队列研究独立交叉核查已核查摘要★ 关键研究5-year survival in childhood ALL rose to 90.4% by 2000-2005.
Most children are cured
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Track ALL survival.
- 研究是如何开展的？
Trial cohort analysis.
- 研究了多少人、动物或样本？
21,626.
- 实际发现了什么？
83.7% -> 90.4%.
- 观察到的效应有多大？
+6.7 points.
- 研究结果对日常生活意味着什么？
Childhood leukaemia is usually curable with treatment.
- 该研究有哪些局限？
Trial patients.
- 它对 Elawady 的具体说法说明了什么？
Benefit side.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
Survival outside trials.
该组中没有被标记为关键研究的研究。
结果不一或不明确的研究 (2)
-
Late deaths among childhood-cancer survivors have fallen as treatment became gentler
Armstrong GT et al.. N Engl J Med 2016 · PMID 26761625 · DOI 10.1056/NEJMoa1510795队列研究被 Tayebat 档案网站引用全文，含结构化偏倚风险评估★ 关键研究15-year death rate after surviving 5 years dropped from 12.4% to 6.0% between the 1970s and 1990s.
41% health-related deaths, but sharp decline
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Track late mortality across eras.
- 研究是如何开展的？
Cohort, 34,033 survivors.
- 研究了多少人、动物或样本？
34,033.
- 实际发现了什么？
41% of late deaths health-related; mortality halved over time.
- 观察到的效应有多大？
12.4% -> 6.0%.
- 研究结果对日常生活意味着什么？
Late effects are real and being reduced.
- 该研究有哪些局限？
Observational era comparison; cannot measure improvements in medical care; treatment data imputed for 29%; shorter follow-up for the 1990s.
- 它对 Elawady 的具体说法说明了什么？
Supports burden and shows progress.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
That treatment should be avoided.
-
Are childhood cancer survivors getting healthier?
Gibson TM et al.. Lancet Oncol 2018 · PMID 30416076 · DOI 10.1016/S1470-2045(18)30537-0队列研究独立交叉核查已核查摘要★ 关键研究Severe long-term conditions fell from 33% to 28% across three decades, but stayed far above siblings (5%).
Confirms burden (27.5% severe vs 4.6% siblings) and shows a decline over treatment eras.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Compare late effects by treatment era
- 研究是如何开展的？
Cohort of 23,601 survivors
- 研究了多少人、动物或样本？
North America, 1970-99
- 实际发现了什么？
Fewer severe conditions in later eras
- 观察到的效应有多大？
33.2% -> 27.5% vs 4.6% siblings
- 研究结果对日常生活意味着什么？
Treatment changes reduced harm; survivors still need follow-up
- 该研究有哪些局限？
Self-report
- 它对 Elawady 的具体说法说明了什么？
Supports burden; counters the idea it is fixed or growing
- 研究结果是否适用于德国和欧洲？
Moderate
- 从该研究中明确不能得出什么结论？
Cannot show treatment should be avoided
该组中没有被标记为关键研究的研究。
地区背景
德国 / 欧盟
Long-term follow-up clinics for survivors exist in Europe.
埃及
No data reviewed.
在我的国家适用什么？
一般科学评估
基本正确 幸存者的疾病负担确实存在，但该档案网站错误陈述了其严重程度，并且没有提到这一负担正在减轻。
该说法涉及生物学或医学关系。上述科学评估不论在哪个国家都适用；各国食品数据不会改变这一评估。
参考文献
- Chronic health conditions in adult survivors of childhood cancer.. Oeffinger KC et al.. N Engl J Med 2006 · PMID 17035650 · DOI 10.1056/NEJMsa060185
- Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.. Mulrooney DA et al.. BMJ 2009 · PMID 19996459 · DOI 10.1136/bmj.b4606
- The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).. Bhakta N et al.. Lancet 2017 · PMID 28890157 · DOI 10.1016/S0140-6736(17)31610-0
- Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.. Hunger SP et al.. J Clin Oncol 2012 · PMID 22412151 · DOI 10.1200/JCO.2011.37.8018
- Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.. Armstrong GT et al.. N Engl J Med 2016 · PMID 26761625 · DOI 10.1056/NEJMoa1510795
- Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.. Gibson TM et al.. Lancet Oncol 2018 · PMID 30416076 · DOI 10.1016/S1470-2045(18)30537-0